HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Andrew S. Wechsler Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wechsler, A. S. Search for Related Content PubMed Articles by Wechsler, A. S. Related Collections Valve disease

J Thorac Cardiovasc Surg 2009;137:267-268
© 2009 The American Association for Thoracic Surgery

Editorial

Mitral valve surgery for functional mitral regurgitation: Should moderate to severe tricuspid regurgitation be treated? A propensity score analysis

Drexel University College of Medicine, Philadelphia, Pa

Received for publication June 10, 2008; accepted for publication July 10, 2008.

^_* Address for reprints: Andrew S. Wechsler, MD, Drexel University College of Medicine, 245 N. 15th St, MS 111, Philadelphia, PA 19102. (Email: andrew.wechsler@drexelmed.edu).

The first 20% of the full text of this article appears below.

Any study designed to examine tricuspid valve intervention in patients with functional tricuspid valve regurgitation (FTR) associated with functional mitral valve regurgitation (FMR) begins with the understanding that FMR in this setting is different from FMR associated with structural mitral valve disease. Operations for structural mitral valve disease are anticipated to correct most of the abnormal physiologic characteristics associated with the volume overload of mitral regurgitation and to promote progressive and durable reverse remodeling. It is thus reasonable to intuit that mild degrees of FTR in this setting are likely to regress or remain the same as pulmonary artery pressures, right ventricular dimensions and function, and left ventricular properties improve with time.

Such is not the case for FMR associated with abnormal left ventricular systolic function. FMR can be surgically corrected with low operative mortality. However, there remains a high recurrence rate, particularly when severe FMR is treated by isolated valve repair rather than replacement.¹ The early changes of reverse left ventricular remodeling are not necessarily sustained, and the progressive nature of the intrinsic cardiomyopathy (ischemic or dilated) commonly resumes after an initial period of improvement.^2,3 A study from the Mayo Clinic found a clear correlation between the extent of functional mitral regurgitation and late mortality. Wu and colleagues,⁴ however, reported no benefit in longevity for patients undergoing operation for . . . [Full Text of this Article]